Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

The efficacy of agomelatine in elderly patients with recurrent major depressive disorder: a placebo-controlled study.

Heun R, Ahokas A, Boyer P, Giménez-Montesinos N, Pontes-Soares F, Olivier V; Agomelatine Study Group..

J Clin Psychiatry. 2013 Jun;74(6):587-94. doi: 10.4088/JCP.12m08250.

PMID:
23842010
2.
3.

Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline.

Kasper S, Hajak G, Wulff K, Hoogendijk WJ, Montejo AL, Smeraldi E, Rybakowski JK, Quera-Salva MA, Wirz-Justice AM, Picarel-Blanchot F, Baylé FJ.

J Clin Psychiatry. 2010 Feb;71(2):109-20. doi: 10.4088/JCP.09m05347blu.

PMID:
20193645
4.

Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study.

Hale A, Corral RM, Mencacci C, Ruiz JS, Severo CA, Gentil V.

Int Clin Psychopharmacol. 2010 Nov;25(6):305-14. doi: 10.1097/YIC.0b013e32833a86aa.

PMID:
20856123
5.

Agomelatine in generalized anxiety disorder: an active comparator and placebo-controlled study.

Stein DJ, Ahokas A, Márquez MS, Höschl C, Oh KS, Jarema M, Avedisova AS, Albarran C, Olivier V.

J Clin Psychiatry. 2014 Apr;75(4):362-8. doi: 10.4088/JCP.13m08433.

PMID:
24569045
6.

Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial.

Zajecka J, Schatzberg A, Stahl S, Shah A, Caputo A, Post A.

J Clin Psychopharmacol. 2010 Apr;30(2):135-44. doi: 10.1097/JCP.0b013e3181d420a7.

PMID:
20520286
7.
8.

Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.

Brecht S, Courtecuisse C, Debieuvre C, Croenlein J, Desaiah D, Raskin J, Petit C, Demyttenaere K.

J Clin Psychiatry. 2007 Nov;68(11):1707-16.

PMID:
18052564
9.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
10.

Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine.

Montgomery SA, Kasper S.

Int Clin Psychopharmacol. 2007 Sep;22(5):283-91.

PMID:
17690597
11.

Placebo-controlled trial of agomelatine in the treatment of major depressive disorder.

Kennedy SH, Emsley R.

Eur Neuropsychopharmacol. 2006 Feb;16(2):93-100.

PMID:
16249073
12.
13.

Comparable efficacy and safety of 8 weeks treatment with agomelatine 25-50mg or fluoxetine 20-40mg in Asian out-patients with major depressive disorder.

Shu L, Sulaiman AH, Huang YS, Fones Soon Leng C, Crutel VS, Kim YS.

Asian J Psychiatr. 2014 Apr;8:26-32. doi: 10.1016/j.ajp.2013.09.009.

PMID:
24655622
14.
15.
16.

Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.

Brannan SK, Mallinckrodt CH, Brown EB, Wohlreich MM, Watkin JG, Schatzberg AF.

J Psychiatr Res. 2005 Jan;39(1):43-53.

PMID:
15504423
18.

Agomelatine prevents relapse in generalized anxiety disorder: a 6-month randomized, double-blind, placebo-controlled discontinuation study.

Stein DJ, Ahokas A, Albarran C, Olivier V, Allgulander C.

J Clin Psychiatry. 2012 Jul;73(7):1002-8. doi: 10.4088/JCP.11m07493.

PMID:
22901350
19.

Is it time to shift to better characterization of patients in trials assessing novel antidepressants? An example of two relapse prevention studies with agomelatine.

Goodwin GM, Boyer P, Emsley R, Rouillon F, de Bodinat C.

Int Clin Psychopharmacol. 2013 Jan;28(1):20-8. doi: 10.1097/YIC.0b013e32835b0814.

PMID:
23151774
20.

Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician.

Reddy S, Kane C, Pitrosky B, Musgnung J, Ninan PT, Guico-Pabia CJ.

Curr Med Res Opin. 2010 Jan;26(1):139-50. doi: 10.1185/03007990903408678. Review.

PMID:
19919295
Items per page

Supplemental Content

Support Center